OpenJournalRank

Current treatment options in infectious diseases/Current treatment options in infectious disease

Springer Science+Business Media · United States

ISSN-L
1523-3820
ISSN
1534-6250
OpenAlex ID
S2764629370
APC list price
$3,890
Full statisticsSubscription or hybridCore list

In 2025, Current treatment options in infectious diseases/Current treatment options in infectious disease had an OJR of 1.13: its 2022–2024 papers received 1.1 times the world-average citations for comparable papers. Its Impact factor (2-year) was 3.10. Both figures are calculated from OpenAlex data. Not ranked in 2025: 24 citable documents in 2022–2024, below the 30-document minimum. Last eligible ranking: Q3 in Public Health, Environmental and Occupational Health, 2023.

Current treatment options in infectious diseases/Current treatment options in infectious disease has no quartile in OpenJournalRank’s 2025 ranking. OJR quartiles are calculated independently of SCImago, Scopus and JCR quartiles.

OpenAlex-listed APC: US$3,890 (source snapshot September 23, 2026). Check current charges with the journal.